Deciphex

Deciphex, founded in 2017 and headquartered in Ireland, operates at the intersection of AI, Biotechnology, and Health Care. The company’s mission, encapsulated by its slogan, “Transforming Pathology using Tailored Workflows and Artificial Intelligence,” emphasizes its commitment to reshaping the pathology landscape.

The startup addresses the critical challenge of a growing pathology workload juxtaposed with a shrinking pool of pathologists. By building a global network of AI-enhanced pathologists, Deciphex is pioneering the development of digital pathology platforms that enable more efficient diagnostic processes, ultimately improving patient outcomes.

Attracting investor attention, Deciphex recently secured a €15.00M Series C investment as of 01 October 2025. This funding underscores investor confidence in their vision to alleviate the looming pathology crisis through innovative technology solutions.